ANRS 12372 MODERATO Study
Condition: HIV-1-infection Interventions: Drug: dolutegravir; Drug: atazanavir boosted with ritonavir; Drug: tenofovir + lamivudine +efavirenz; Drug: Lamivudine Sponsors: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS); Mylan Laboratories Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials